P

Inventor

KHAIRATKAR-JOSHI NEELIMA

IN44 patents
⚠️ This page may combine multiple inventors who share the name “KHAIRATKAR-JOSHI NEELIMA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GLENMARK PHARMACEUTICALS SA

24 patents
US9439890B2Sep 13, 2016

Triazolone compounds as mPGES-1 inhibitors

GLENMARK PHARMACEUTICALS SA4 citations82
US9096545B2Aug 4, 2015

Triazolone compounds as mPGES-1 inhibitors

GLENMARK PHARMACEUTICALS SA7 citations82
US9855229B2Jan 2, 2018

Treatment of respiratory disorders using ROR-gamma inhibitors

GLENMARK PHARMACEUTICALS SA12 citations76
US10821100B2Nov 3, 2020

Triazolone compounds as mPGES-1 inhibitors

GLENMARK PHARMACEUTICALS SA1 citations71
US10391083B2Aug 27, 2019

Triazolone compounds as MPGES-1 inhibitors

GLENMARK PHARMACEUTICALS SA1 citations71
US9949955B2Apr 24, 2018

Triazolone compounds as mPGES-1 inhibitors

GLENMARK PHARMACEUTICALS SA2 citations71
US7842703B2Nov 30, 2010

Substituted benzofused derivatives and their use as vanilloid receptor ligands

GLENMARK PHARMACEUTICALS SA7 citations68
US7951814B2May 31, 2011

Quinazolinedione derivatives as TRPA1 modulators

GLENMARK PHARMACEUTICALS SA4 citations58
US10988467B2Apr 27, 2021

Compounds as ROR gamma modulators

GLENMARK PHARMACEUTICALS SA0 citations57
US8349846B2Jan 8, 2013

Fused pyrimidine derivatives as TRPV3 modulators

GLENMARK PHARMACEUTICALS SA2 citations56
US9474758B2Oct 25, 2016

Thienopyrimidinedione derivatives as TRPA1 modulators

GLENMARK PHARMACEUTICALS SA0 citations49
US8987278B2Mar 24, 2015

Thienopyrimidinedione derivatives as TRPA1 modulators

GLENMARK PHARMACEUTICALS SA1 citations49
US9073955B2Jul 7, 2015

2-amino-4-arylthiazole compounds as TRPA1 antagonists

GLENMARK PHARMACEUTICALS SA0 citations48
US8889862B2Nov 18, 2014

2-amino-4-arylthiazole compounds as TRPA1 antagonists

GLENMARK PHARMACEUTICALS SA0 citations48
US10344024B2Jul 9, 2019

Compounds as ROR gamma modulators

GLENMARK PHARMACEUTICALS SA0 citations47
US9975887B2May 22, 2018

Compounds as ROR gamma modulators

GLENMARK PHARMACEUTICALS SA0 citations47
US9000159B2Apr 7, 2015

Fused pyrimidine-dione derivatives as TRPA1 modulators

GLENMARK PHARMACEUTICALS SA1 citations47
US10336688B2Jul 2, 2019

Carbocyclic compounds as ROR gamma modulators

GLENMARK PHARMACEUTICALS SA0 citations46
US10189775B2Jan 29, 2019

Carbocyclic compounds as ROR gamma modulators

GLENMARK PHARMACEUTICALS SA0 citations46
US9682977B2Jun 20, 2017

Bicyclic heteroaryl indole analogues useful as ROR gamma modulators

GLENMARK PHARMACEUTICALS SA1 citations45
US9006257B2Apr 14, 2015

Bicyclic compounds as mPGES-1 inhibitors

GLENMARK PHARMACEUTICALS SA0 citations40
US10758517B2Sep 1, 2020

mPGES-1 inhibitor for the treatment of osteoarthritis pain

GLENMARK PHARMACEUTICALS SA0 citations38
US8344010B2Jan 1, 2013

Fused imidazole derivatives as TRPV3 antagonist

GLENMARK PHARMACEUTICALS SA0 citations35
US9718817B2Aug 1, 2017

Aryl and heteroaryl ether compounds as ROR gamma modulators

GLENMARK PHARMACEUTICALS SA0 citations30

GLENMARK SPECIALTY SA

7 patents

KUMAR SUKEERTHI

3 patents

CHAUDHARI SACHIN SUNDARLAL

2 patents

GLENMARK PHARMACEUTICALS LTD

2 patents

LINGAM V S PRASADA RAO

2 patents

KHAIRATKAR-JOSHI NEELIMA

1 patent

LINGAM PRASADA RAO V S

1 patent

GHARAT LAXMIKANT A

1 patent

LINGAM V S PRASADARAO

1 patent